FindTrial
Sign In

Clinical research of Jinfeng pills to improve the outcome in poor ovarian responders undergoing in vitro fertilization and embryo transfer

Clinical research of Jinfeng pills to improve the outcome in poor ovarian responders undergoing in vitro fertilization and embryo transfer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051925
Enrollment
Unknown
Registered
2021-10-09
Start date
2021-10-09
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

poor ovarian responder

Interventions

Experimental group:Jinfeng pills
Control group:None

Sponsors

Sichuan Provincial Women's and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients diagnosed with POR according to Bologna criteria.

Exclusion criteria

Exclusion criteria: 1.Combined with congenital uterine malformation, endometriosis, polycystic ovary syndrome; 2.Combined with uterine cavity adhesion; 3.Patients with only unilateral ovary due to surgery and other reasons; 4.Patients with systemic lupus erythematosus, sjogren's syndrome and other immune diseases; 5.Uncontrolled diabetes, thyroid dysfunction, hyperprolactinemia, etc.; 6.The husband's sperm quality is poor and needs to use oocyte single sperm microinjection; 7.Patients who are allergic to Jinfeng pills or have had adverse reactions; 8.Combined use of other drugs to improve ovarian reserve, such as vitamin E, coenzyme Q10, etc.

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rate;—

Countries

China

Contacts

Public ContactGong Yan

Sichuan Provincial Women's and Children's Hospital

gongyan_496181657@qq.com+86 15208393996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026